On May 28, 2024 Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, reported that the Company will present at the following upcoming investor conferences during the month of June (Press release, Dynavax Technologies, MAY 28, 2024, View Source [SID1234643730]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
William Blair 44th Annual Growth Stock Conference on Tuesday, June 4 at 1:20 p.m. CT
Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10 at 4:00 p.m. ET
The presentations will be webcast and may be accessed through the "Events & Presentations" page on the "Investors" section of the Company’s website at View Source